Lemaitre Vascular (LMAT) Misses Q4 EPS by 1c, Offers Guidance
Get Alerts LMAT Hot Sheet
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.25, $0.01 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $41 million versus the consensus estimate of $41 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2023 EPS of $0.22-$0.27, versus the consensus of $0.27. Lemaitre Vascular sees Q1 2023 revenue of $42.6-45 million, versus the consensus of $41.6 million.
Lemaitre Vascular sees FY2023 EPS of $1.11-$1.20, versus the consensus of $1.19. Lemaitre Vascular sees FY2023 revenue of $174.3-178.3 million, versus the consensus of $171.4 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- The LGL Group (LGL) Misses Q2 EPS by 8c
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share